| abstract |
The invention relates to a method for evaluating the potential of a chemical entity, such as an antibody, to bind to a peptide antigenic determinant from the binding site of the bivalent sialosides of hemagglutinin, a protein of the influenza virus. . The invention also provides peptide antigenic determinants useful in the prevention and / or treatment of influenza or for the development of such treatment or vaccine against influenza. |